Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2024
11-1-2024 Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome, Mariam A. Mostafa, Rochester Regional Health, Martin Zand, University of Rochester, Rochester, New York, USA., Jeremy Taylor, University of Rochester, Rochester, New York, USA., et al.
10-3-2024 MGUS Everywhere: What Does it Mean and What to do About it, Adam Starr, Rochester Regional Health
10-2024 P1.13A.10 Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study, Balazs Halmos, Philip Lammers, G Liu, et al.
9-26-2024 Two Sides of a Coin: Navigating Complexities of Pain Management, Tripti Jain, Rochester Regional Health and Erin Klinkman, Rochester Regional Health
9-12-2024 Palliative Care Top 5, Adam Herman, Rochester Regional Health; Michael Disalle, Rochester Regional Health; Jonathan Steiner, Rochester Regional Health; Joshua Jones, Rochester Regional Health; and James Fennelly, Rochester Regional Health
9-1-2024 Arrhythmia: Cancer in Disguise?, Zeni Kharel, Rochester Regional Health; Mohammad Talal Khan, Rochester Regional Health; and Christopher T. Sciria, Department of Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY.
9-2024 Changing Complete Blood Count Would Be ‘Another Hassle’ for Medicine, Ronald Sham, Rochester Regional Health
9-1-2024 Impact of anticoagulation therapy on outcomes in patients with cirrhosis and portal vein thrombosis: A large-scale retrospective cohort study, Chengu Niu, Rochester Regional Health, Jing Zhang, Rainier Springs Behavioral Health Hospital, Vancouver, WA 98686, USA., Kharel Himal, Rochester Regional Health, et al.
8-21-2024 Incessant Ventricular Tachycardia: An Atypical Presentation of Chronic Eosinophilic Leukemia, Andrew Takla, Rochester Regional Health, Purva Shah, Rochester Regional Health, Maria Sbenghe, Rochester Regional Health, et al.
8-1-2024 Generalized pustular psoriasis successfully treated with spesolimab in the setting of metastatic colon cancer, Diamond Rose Guy, University of Rochester School of Medicine and Dentistry, Rochester, New York., Sydney DeVore, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Vatsala Kirtani, Rochester Regional Health, et al.
7-2024 PP01.119 Real-World Use of Lurbinectedin in Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Updated Analysis, Balazs Halmos, Philip Lammers, Mehul Patel, Rochester Regional Health, et al.
6-28-2024 A Case of Unusual Cytopenias in CLL, Zeni Kharel, Rochester Regional Health; Himal Kharel, Rochester Regional Health; and Pradyumna Phatak, Rochester Regional Health
6-19-2024 Breast Cancer Screening Using Inverse Modeling of Surface Temperatures and Steady-State Thermal Imaging, Nithya Sritharan, Rochester Regional Health, Carlos Gutierrez, Department of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA., Isaac Perez-Raya, Department of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA., et al.
6-1-2024 Diagnosing aceruloplasminemia: navigating through red herrings, Zeni Kharel, Rochester Regional Health; Himal Kharel, Rochester Regional Health; and Pradyumna D. Phatak, Rochester Regional Health
6-2024 First reported use of immune checkpoint inhibitor for treatment of cancer in a patient with acquired hemophilia A, Mariam A.O. Mostafa, Rochester Regional Health, Sheref Elseidy, Rochester Regional Health, Reham Ali Metwally, et al.
6-1-2024 Hospitalization outcomes of patients with colorectal cancer (CRC) admitted with Clostridioides difficile colitis, Aditya Sanjeevi, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., Himal Kharel, Rochester Regional Health, et al.
6-1-2024 Is essential thrombocytosis associated with worse outcomes in patients with stroke? Results from 2016-2020 National Inpatient Sample study, Himal Kharel, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., Zeni Kharel, Rochester Regional Health, et al.
6-1-2024 Navigating the Complexities of Brain Metastases Management, Afsaneh Amouzegar, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Shannon Haig, Lake Erie College of Osteopathic Medicine, Greensburg, PA., Adriana M. Kahn, Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT., et al.
6-1-2024 Unveiling a low-hanging fruit: Single-center study on secondary immunodeficiency in newly diagnosed chronic lymphocytic leukemia and multiple myeloma, Zeni Kharel, Rochester Regional Health, Himal Kharel, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
6-1-2024 When pain management meets harm reduction: Patients with cancer navigate the opioid crisis—2016 to 2020 National Inpatient Sample analysis, Himal Kharel, Rochester Regional Health, Zeni Kharel, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., et al.
5-1-2024 Abstract PO1-07-12: Inverse modeling with surface temperature accurately detects the presence of breast cancer, Nithya Sritharan, Rochester Regional Health, Carlos Gutierrez, Isaac Perez-Raya, et al.
5-1-2024 Abstract PO3-06-03: Overall Survival and Disease Interval Among Breast Cancer Subtypes in Patients with Brain Metastasis, Asis Shrestha, Sugam Gouli, Rochester Regional Health, Sujan Niraula, et al.
5-1-2024 Abstract PO4-20-11: Excellent Response to Trastuzumab Deruxtecan in “HER-2 Low” Leptomeningeal Breast Cancer and Diagnostic and Monitoring Utility of CNSide Assay, Sarah Stanford, Zeni Kharel, Rochester Regional Health, Lauryn Hemminger, et al.
5-1-2024 Transplacental transfer of emicizumab: Experience with emicizumab in a pregnant female with severe hemophilia A and an inhibitor, Zeni Kharel, Rochester Regional Health, Rajiv K. Pruthi, Division of Hematopathology, Comprehensive Hemophilia Center and Special Coagulation Laboratory, Mayo Clinic, Rochester, Minnesota, USA., Peter Kouides, Rochester Regional Health, et al.
4-18-2024 Immune-Related Adverse Events of Immune Checkpoint Inhibitors, Charoo Iyer, Rochester Regional Health; Chengu Niu, Rochester Regional Health; Ido Goldenberg, Rochester Regional Health; and Mehul Patel, Rochester Regional Health